271 related articles for article (PubMed ID: 8260360)
1. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
[TBL] [Abstract][Full Text] [Related]
2. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
3. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.
Bennett MH; Wilson GD; Dische S; Saunders MI; Martindale CA; Robinson BM; O'Halloran AE; Leslie MD; Laing JH
Br J Cancer; 1992 Jun; 65(6):870-8. PubMed ID: 1616858
[TBL] [Abstract][Full Text] [Related]
4. Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
Forster G; Cooke TG; Cooke LD; Stanton PD; Bowie G; Stell PM
Br J Cancer; 1992 May; 65(5):698-702. PubMed ID: 1586597
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation kinetics of six xenografted human cervix carcinomas: comparison of autoradiography and bromodeoxyuridine labelling methods.
van Oostrum IE; Rozemuller E; Knol RF; Erkens-Schulze S; Rutgers DH
Cell Tissue Kinet; 1990 Nov; 23(6):523-44. PubMed ID: 2276171
[TBL] [Abstract][Full Text] [Related]
6. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
[TBL] [Abstract][Full Text] [Related]
7. Cell kinetics of head and neck squamous cell carcinomas. Prognostic implications.
Nylander K; Anneroth G; Gustafsson H; Roos G; Stenling R; Zackrisson B
Acta Oncol; 1994; 33(1):23-8. PubMed ID: 8142119
[TBL] [Abstract][Full Text] [Related]
8. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.
Høyer M; Jørgensen K; Bundgaard T; Johansen LV; Bentzen SM; Overgaard M; Hansen O; Søgaard H; Overgaard J
Radiother Oncol; 1998 Feb; 46(2):147-55. PubMed ID: 9510042
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different labelling index formulae used on bromodeoxyuridine-flow cytometry data.
Johansson MC; Johansson R; Baldetorp B; Oredsson SM
Cytometry; 1998 Jul; 32(3):233-40. PubMed ID: 9667513
[TBL] [Abstract][Full Text] [Related]
10. Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study.
Rew DA; Thomas DJ; Coptcoat M; Wilson GD
Br J Urol; 1991 Jul; 68(1):44-8. PubMed ID: 1873691
[TBL] [Abstract][Full Text] [Related]
11. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
[TBL] [Abstract][Full Text] [Related]
12. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.
Wilson GD; McNally NJ; Dische S; Saunders MI; Des Rochers C; Lewis AA; Bennett MH
Br J Cancer; 1988 Oct; 58(4):423-31. PubMed ID: 3207597
[TBL] [Abstract][Full Text] [Related]
13. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
14. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
Begg AC; Moonen L; Hofland I; Dessing M; Bartelink H
Radiother Oncol; 1988 Apr; 11(4):337-47. PubMed ID: 3375460
[TBL] [Abstract][Full Text] [Related]
15. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
16. Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.
Begg AC; Hofland I; Kummermehr J
Eur J Cancer; 1991; 27(5):537-43. PubMed ID: 1828958
[TBL] [Abstract][Full Text] [Related]
17. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
Wilson GD; Dische S; Saunders MI
Radiother Oncol; 1995 Sep; 36(3):189-97. PubMed ID: 8532905
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
Webster L; Hodgkiss RJ; Wilson GD
Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
[TBL] [Abstract][Full Text] [Related]
20. Influence of sampling time on assessment of potential doubling time.
Høyer M; Bentzen SM; Salling LN; Overgaard J
Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]